Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2-advanced/metastatic breast cancer: Results from a Phase Ib clinical trial Meeting Abstract


Authors: Bardia, A.; Chavez-MacGregor, C.; Modi, S.; Campone, M.; Ma, B.; Kittaneh, M.; Dirix, L.; Motta, M.; Zhang, V.; Bhansali, S.; Fjaellskog, M. L.; Oliveira, M.
Abstract Title: Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2-advanced/metastatic breast cancer: Results from a Phase Ib clinical trial
Meeting Title: 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: European Journal of Cancer
Volume: 50
Issue: Suppl. 6
Meeting Dates: 2014 Nov 18-21
Meeting Location: Barcelona, Spain
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2014-11-01
Start Page: 163
Language: English
ACCESSION: WOS:000347755700501
PROVIDER: wos
DOI: 10.1016/S0959-8049(14)70626-4
Notes: Meeting Abstract: 500 -- 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 18-21, 2014 -- Barcelona, SPAIN -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shanu Modi
    265 Modi